Offer - Urjas Oil for just ₹ 1 X
Neurigab NT is an allopathic medicine The correct dosage of Neurigab NT depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Neurigab NT is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Is the use of Neurigab NT safe for pregnant women?
Neurigab NT may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Neurigab NT again without your doctor's advice.
Is the use of Neurigab NT safe during breastfeeding?
Women who are breastfeeding may experience severe harmful effects after taking Neurigab NT. It should only be taken after medical advice.
What is the effect of Neurigab NT on the Kidneys?
Neurigab NT is not harmful for kidneys.
What is the effect of Neurigab NT on the Liver?
Very few cases of side effects of Neurigab NT on the liver have been reported.
What is the effect of Neurigab NT on the Heart?
Neurigab NT is rarely harmful for the heart.
Neurigab NT should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Neurigab NT unless your doctor advises you to do so -
Is this Neurigab NT habit forming or addictive?
No, there is no any evidence that Neurigab NT is addictive.
Is it safe to drive or operate heavy machinery when consuming?
After taking Neurigab NT you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, Neurigab NT is safe but you must consult your doctor before taking it.
Is it able to treat mental disorders?
Yes, this Neurigab NT works for mental disorders.
Interaction between Food and Neurigab NT
Taking Neurigab NT with food does not cause any problems.
Interaction between Alcohol and Neurigab NT
Consuming Neurigab NT with alcohol can have many serious effects on your body.
Yes, Neurigab NT is safe to use, if taken prescribed quantity for the prescribed duration as directed by the doctor. However, there is fewer side effects are observed at a therapeutic dose like drowsiness, dizziness, blurred vision, and constipation.
Yes, long-term use of Neurigab NT can cause weight gain. It is a known side effect of this drug. It is presumed that it causes weight gain by increasing the appetite as well as sedentary lifestyle also contributes to weight gain. However, the exact cause of weight gain after taking Neurigab NT is unknown.
Neurigab NT is a brand name for gabapentin it comes in the form of a tablet (solid unit dosage form), capsule and oral solution. It is a prescription drug which belongs to the class of drugs known as anti-convulsants or antiepileptic drug. It is mainly used in the treatment of neuropathic pain (pain that arises due to damage to the nervous system) and partial seizure in adult and children. It is also used to relieve pain from postherpetic neuralgia.
Yes Neurigab NT can cause depression. It is known side effect of this drug. It acts on the brain and decreases certain brain activity which results in depression and reduced arousal.
Neurigab NT is safe to use for longer time. Take it as directed by your doctor. Do not discontinue the treatment suddenly or take longer than prescribed duration as advice doctor.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Neurontin® (gabapentin)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 419-420
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 605-606
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 924-925
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Pamelor® (nortriptyline hydrochloride)